Since 2006, Eurofarma has publicly presented its financial results and a summary of its annual actions.
To guide the content reported in its reports, the company included the information obtained in its results and in consultations with its main stakeholders, who highlighted the topics they considered important to see portrayed. It also considered its strategic planning aligned with Vision 2027, which will guide it for the next five years, in addition to trends and challenges in the pharmaceutical sector.
The 2024 Report, referring to the financial year from January 1st to December 31st, 2023, was prepared in accordance with the standards of the Global Reporting Initiative (GRI Standards) and also includes SASB (Sustainability Accounting Standards Board) indicators for Biotechnology & Pharmaceuticals (Biotechnology & Pharmaceuticals). The content presents a direct report based on data on topics that are relevant to society, employees and the market.
Good reading!
